The Drug Enforcement Administration permits a pharmacist to dispense a Schedule II controlled substance prescription in separate partial quantities, but only within the narrow circumstances set out at 21 CFR 1306.13. For a pharmacist-in-charge, the timing and the paperwork around a partial fill are exactly the kind of small, correctable-looking detail that can surface months later as a discrepancy during a DEA audit or a registrant action. The regulation covers three distinct scenarios, and each one carries its own clock and its own documentation requirements.
When Partial Fills Are Permitted
Three separate situations authorize a partial fill of a Schedule II prescription. Under 21 CFR 1306.13(a), a pharmacist unable to supply the full quantity written on a prescription may dispense what is available and fill the remainder later. Under 21 CFR 1306.13(b), a patient, caregiver, or the prescribing practitioner may request a partial fill outright, a mechanism Congress created in 2016 through CARA's amendment to the Controlled Substances Act, codified at 21 U.S.C. 829(f), and that the DEA implemented through a final rule effective August 21, 2023. Under 21 CFR 1306.13(c), prescriptions written for a patient in a long term care facility or for a patient with a documented terminal illness may be filled in partial quantities, down to individual dosage units, without a new prescription for each fill.
Timing Limits Between Partial Fills
Each scenario runs on a different deadline. Under the unable-to-supply rule, the remaining quantity must be filled within 72 hours of the first partial filling; after that window closes, the pharmacist must notify the prescriber, and no further quantity may be dispensed without a new prescription. For a patient- or practitioner-requested partial fill of a non-emergency prescription, the remaining portion must be filled within 30 days of the date the prescription was written, or within 72 hours for an emergency oral prescription. For long term care facility and terminally ill patients, the prescription itself remains valid for 60 days from the date it was issued unless the medication is discontinued sooner, and partial fills may continue against it throughout that period.
A partial fill that is not documented to DEA's specifications reads, on audit, exactly like a missing dose.
Documentation Every Partial Fill Requires
For each partial filling, the pharmacist must record the date, the quantity dispensed, the quantity still remaining, and the identity of the dispensing pharmacist, either on the back of the written prescription or in another uniformly maintained, readily retrievable record. The record must also state whether the patient or caregiver requested the fill or the practitioner authorized it, and, for long term care facility or terminally ill patients, which category applies. Across every partial filling, the total quantity dispensed cannot exceed the total quantity prescribed. These entries have to reconcile against the pharmacy's controlled substance inventory down to the dose, and gaps in them are among the dispensing red flags DEA investigators look for during an inspection.
Why Early Legal Counsel Is Critical
It is critical that pharmacies and pharmacists-in-charge promptly retain experienced healthcare defense counsel upon receiving a DEA administrative inspection warrant, subpoena, or order to show cause tied to controlled substance dispensing records. Early legal intervention can protect the pharmacy's registration, ensure appropriate responses to government requests, avoid inadvertent admissions, preserve relevant defenses, and allow counsel to communicate with investigators on the pharmacy's behalf. Delaying legal representation can significantly affect the outcome of a matter, including whether the DEA pursues an immediate suspension order rather than a less severe administrative remedy, and can expose the pharmacy to unnecessary risk.
How Health Law Alliance Can Help
Health Law Alliance has spent 25+ years defending pharmacies and pharmacists against DEA registrant actions built on dispensing and recordkeeping discrepancies, including disputes that begin with partial-fill documentation. The firm's DEA defense attorneys respond to administrative inspections, subpoenas, and orders to show cause, and work to resolve inventory reconciliation questions before they escalate into registration proceedings. Pharmacies facing a DEA inquiry can contact Health Law Alliance for a free, confidential consultation.
